Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalation vs TIVA in Transaxillary Endoscopic Breast Augmentation
NCT04036487Completed
- Start
- Jul 2017
- Primary completion
- May 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised trial of desflurane in Breast augmentation (2 arms). Primary endpoint: Quality of recovery at 1 day. Started Jul 2017; status: completed.
02
Drugs
desflurane
03
Conditions
Breast augmentation
Beyond the preview
Go deeper on NCT04036487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036487.